Initial Treatment With Tebentafusp Show Significant OS Improvement in Metastatic Uveal Melanoma
…potential to be practice-changing in uveal melanoma.” Uveal melanoma is a rare disease with a low mutational burden and a…
Initial Treatment With Tebentafusp Show Significant OS Improvement in Metastatic Uveal Melanoma
…potential to be practice-changing in uveal melanoma.” Uveal melanoma is a rare disease with a low mutational burden and a…
,
,
Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Combination with Pembrolizumab in Advanced Melanoma at ASCO 2021 Annual Meeting
…a potential additive effect for early-line treatment of patients with melanoma. I look forward to investigating this treatment approach in…
,
Istari Oncology Announces FDA Granted Fast Track Designation to PVSRIPO for the Treatment of Advanced Melanoma
…advanced melanoma earlier this year.“We are thrilled with FDA’s decision to grant both Fast Track and Orphan Drug Designation to…
,
,
FDA Approves KEYTRUDA for Stage IIB and IIC Melanoma Patients
…their melanoma returning.” Patients will appreciate this new treatment option after a Stage IIB or IIC diagnosis. “Melanoma patients will…
,
,
Coolibar’s Generous Donation to the AIM at Melanoma Foundation
…at Melanoma’s Mission AIM at Melanoma Foundation is committed to supporting patients with melanoma, educating the public about sun safety,…
,
AIM at Melanoma’s 4th Annual Evening in Memory of Valerie Guild
On Saturday, May 31st, AIM supporters, including many influential figures in the melanoma community, gathered for AIM at Melanoma’s 4th…
,
FDA Does Not Approve RP1 in Combination with Nivolumab for Advanced Melanoma: What This Means for Patients
…unmet need. More treatment options are needed for these patients. “This is not the outcome the melanoma community had hoped…
,
,
Women in Melanoma: A New Chapter in Europe
…important step together with Liga os Pontos – Associação Portuguesa de Melanoma, united by a shared commitment to the melanoma…
,
Julie Frampton: Part of the Solution
…M.D. Anderson Cancer Center for the surgery, a second opinion on the pathology report, and a diagnosis. Her melanoma is…
,
,
President’s Letter |September 2020
From the Desk of Samantha Guild The f all is upon us, and here at AIM at Melanoma, we’re busy…
,
Recent Posts
Aug. 31, 2026
Women in Melanoma: A New Chapter in Europe
Aug. 31, 2026
The Legal & Financial Side of a Diagnosis: What No One Tells You
Aug. 19, 2026
Positive Phase 3 Results for Personalized mRNA Therapy in Melanoma
Aug. 07, 2026
RP1 Approved: A Long Road to a New Option for Patients
Aug. 06, 2026